Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Ceftriaxone therapy of serious bacterial infections in adults
M. J. Bittner
, D. L. Dworzack
, L. C. Preheim
, R. W. Tofte
, K. B. Crossley
Medicine - Veteran's Administration Medical Center
Research output
:
Contribution to journal
›
Article
›
peer-review
25
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ceftriaxone therapy of serious bacterial infections in adults'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Ceftriaxone
100%
Serious Bacterial Infection
100%
Aerobic
33%
Thrombocytopenia
33%
Clinical Efficacy
16%
Diarrhea
16%
Twice Daily
16%
Staphylococcus Aureus
16%
Pseudomonas Aeruginosa (P. aeruginosa)
16%
Otitis Media
16%
Catheter-related
16%
Serious Infection
16%
Anaerobic Organism
16%
Drug Administration
16%
Leukopenia
16%
Candidiasis
16%
Skin Tissue
16%
Enterobacteriaceae
16%
Nosocomial Infection
16%
Septicemia
16%
Underlying Disease
16%
Eosinophilia
16%
Adverse Reactions
16%
Infection Site
16%
Urinary Tract Infection
16%
Abdominal Pain
16%
Gram-negative Rods
16%
Respiratory Infection
16%
Ultra-high Performance Liquid Chromatography (UHPLC)
16%
Soft Tissue Infection
16%
Bone Infection
16%
Gram-positive Cocci
16%
Disc Diffusion
16%
Phlebitis
16%
Daily Regimen
16%
Liver Abscess
16%
In(III)
16%
Joint Infection
16%
Otitis Externa
16%
Pharmacology, Toxicology and Pharmaceutical Science
Bacterial Infection
100%
Ceftriaxone
100%
Infection
50%
Thrombocytopenia
33%
Drug Administration
16%
Gram Negative Bacterium
16%
Gram Positive Cocci
16%
Diarrhea
16%
Pseudomonas aeruginosa
16%
Soft Tissue Infection
16%
Adverse Event
16%
Septicemia
16%
Hyperbarism
16%
Hospital Infection
16%
Abdominal Pain
16%
External Otitis
16%
Bone and Joint Infections
16%
Candidiasis
16%
Urinary Tract Infection
16%
Staphylococcus Aureus
16%
Enterobacteriaceae
16%
Otitis Media
16%
Eosinophilia
16%
Respiratory Tract Infection
16%
Leukopenia
16%
Phlebitis
16%
Liver Abscess
16%
Anaerobe
16%
Diseases
16%